Literature DB >> 21039216

Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children.

Cornelia Feiterna-Sperling1, Anke Edelmann, Renate Nickel, Klaus Magdorf, Frank Bergmann, Peter Rautenberg, Brunhilde Schweiger, Volker Wahn, Detlev H Krüger, Jörg Hofmann.   

Abstract

Patients infected with human immunodeficiency virus type 1 (HIV-1) are considered to be at increased risk for 2009 H1N1 influenza-related complications. We performed an observational study after an outbreak of 2009 H1N1 influenza virus infection among a group of 15 HIV-1-infected school-aged children in Germany in October 2009. Clinical course, kinetics of viral shedding, and antibody response among children with CD4 cell counts >350 cells/μL and 2009 H1N1 influenza virus coinfection did not appear to differ from that among healthy children. Oseltamivir shortened the duration of viral shedding.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21039216     DOI： 10.1086/657121

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

1.  Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics.

Authors:  George K Siberry; Mark J Abzug; Sharon Nachman; Michael T Brady; Kenneth L Dominguez; Edward Handelsman; Lynne M Mofenson; Steve Nesheim
Journal:  Pediatr Infect Dis J       Date:  2013-11       Impact factor: 2.129

Review 2.  Influenza and HIV: lessons from the 2009 H1N1 influenza pandemic.

Authors:  Anandi N Sheth; Pragna Patel; Philip J Peters
Journal:  Curr HIV/AIDS Rep       Date:  2011-09       Impact factor: 5.071

3.  Viral shedding in patients infected with pandemic influenza A (H1N1) virus in Kenya, 2009.

Authors:  Lilian W Waiboci; Emmaculate Lebo; John M Williamson; William Mwiti; Gilbert K Kikwai; Henry Njuguna; Beatrice Olack; Robert F Breiman; M Kariuki Njenga; Mark A Katz
Journal:  PLoS One       Date:  2011-06-10       Impact factor: 3.240

4.  Pandemic (H1N1) 2009 and HIV Infection.

Authors:  Shireesha Dhanireddy; Robert D Harrington; Heidi M Crane; Matthew R Gingo; Alison Morris; Laurence Huang; Kristina Crothers
Journal:  Emerg Infect Dis       Date:  2011-06       Impact factor: 6.883

5.  An analysis of 332 fatalities infected with pandemic 2009 influenza A (H1N1) in Argentina.

Authors:  Ana M Balanzat; Christian Hertlein; Carlos Apezteguia; Pablo Bonvehi; Luis Cámera; Angela Gentile; Oscar Rizzo; Manuel Gómez-Carrillo; Fatima Coronado; Eduardo Azziz-Baumgartner; Pollyanna R Chávez; Marc-Alain Widdowson
Journal:  PLoS One       Date:  2012-04-10       Impact factor: 3.240

6.  Pharmacologic effects of oseltamivir in immunocompromised adult patients as assessed by population PK/PD analysis and drug-disease modelling for dosing regimen optimization.

Authors:  Stefan Sturm; Annabelle Lemenuel-Diot; Kashyap Patel; Leonid Gibiansky; Rajinder Bhardwaj; Patrick F Smith; Steve Dang; Elke Zwanziger; Clare Nasmyth-Miller; Patanjali Ravva
Journal:  Br J Clin Pharmacol       Date:  2020-09-09       Impact factor: 4.335

7.  Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine.

Authors:  Claire-Anne Siegrist; Christian van Delden; Michael Bel; Christophe Combescure; Cécile Delhumeau; Matthias Cavassini; Olivier Clerc; Sara Meier; Karine Hadaya; Paola M Soccal; Sabine Yerly; Laurent Kaiser; Bernard Hirschel; Alexandra Calmy
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

8.  HIV-1 and its gp120 inhibits the influenza A(H1N1)pdm09 life cycle in an IFITM3-dependent fashion.

Authors:  Milene Mesquita; Natalia Fintelman-Rodrigues; Carolina Q Sacramento; Juliana L Abrantes; Eduardo Costa; Jairo R Temerozo; Marilda M Siqueira; Dumith Chequer Bou-Habib; Thiago Moreno L Souza
Journal:  PLoS One       Date:  2014-06-30       Impact factor: 3.240

9.  HIV virological suppression influences response to the AS03-adjuvanted monovalent pandemic influenza A H1N1 vaccine in HIV-infected children.

Authors:  Timothy R Leahy; Michelle Goode; Paul Lynam; Patrick J Gavin; Karina M Butler
Journal:  Influenza Other Respir Viruses       Date:  2014-02-18       Impact factor: 4.380

10.  Pandemic Influenza A (H1N1) Virus Infection Increases Apoptosis and HIV-1 Replication in HIV-1 Infected Jurkat Cells.

Authors:  Xue Wang; Jiying Tan; Santanu Biswas; Jiangqin Zhao; Krishnakumar Devadas; Zhiping Ye; Indira Hewlett
Journal:  Viruses       Date:  2016-02-02       Impact factor: 5.048
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.